Error: Twitter did not respond. Please wait a few minutes and refresh this page.
Tag Archives: CML
Like Pfizer’s Bosulif, newly approved Synribo (from Teva Pharmaceuticals) gives CML patients options. As I mentioned in my September post about Bosulif, CML patients have a specific type of genetic mutation called the Philadelphia chromosome. This mutation causes bone marrow to make an enzyme … Continue reading
Over the past several years, LLS has been working hard to get new therapies to patients with some of the rarer forms of blood cancer. So it’s nice to see the FDA approve a new drug that aligns so well … Continue reading
What do zebrafish and people have in common? More than you might think actually. The zebrafish genome and immune system is similar to ours. So scientists can use them as models to identify molecules that kill leukemia cells. Last month researchers … Continue reading
Today Penn State researchers announced that they have discovered a compound in fish oil that appears to target leukemia stem cells and could lead to a cure. “Holy fish oil Batman!” Past research with fatty acids shows that they have … Continue reading